Canaccord Genuity Maintains Buy On Venaxis, Sees 184% Upside
Canaccord Genuity analyst Mark Massaro maintained a Buy rating on Venaxis Inc (NASDAQ:APPY) with a $5.00 price target, which represents a potential upside of 184% from where the stock is currently trading.
Massaro wrote, “Venaxis provided a brief investor call detailing its recent FDA response to FDA’s request for additional information which largely focused on routine product labeling and additional analytical data. We continue to expect FDA approval of APPY-1 by the end of Q2/15. Upon clearance, APPY-1 would become the first diagnostic test used to rule out appendicitis in the ER.”
According to TipRanks.com, which measures analysts’ and bloggers’ success rate based on how their calls perform, analyst Mark Massaro has a total average return of 1.8% and a 68.8% success rate. Massaro is ranked #1866 out of 3401 analysts.